The Antibody Drug Conjugates Market Is Predicted To Reach USD 28.3 Billion By 2023 With A CAGR Of 24.5% According To Market Data Forecast Report.

The Antibody Drug Conjugates Market Is Predicted To Reach USD 28.3 Billion By 2023 With A CAGR Of 24.5% According To Market Data Forecast Report.

ID: 6021 | October 2018 | Region: Global


The Antibody Drug Conjugates Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Antibody Drug Conjugates Market is estimated to be USD 9.46 Billion in 2018 and predicted to rise to USD 28.3 billion by 2023 with a CAGR of 24.5%. The market is segmented by Pipeline Analysis (Phase, Mode of Action [IgG1 antibodies, HER2 antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research institutes, Hospitals, Clinics and Others). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Factors like rise in cancer incidences, changing lifestyles, high investments by the companies in the pipeline analysis, cancer killing ability and research development of ADCs, growing biomedical industry, new product innovations and technology advancements are driving the Global Antibody Drug Conjugates Market. However, high cost of production of ADCs and stringent regulations for the product approval are hindering the growth of the market.

In application, research institutes have the largest share in terms of revenue due to the high funding by the government in order to treat cancer cells and high investment by the private companies.

North America is dominating the global market due to the presence of large companies in this area and their high investment in the cancer product pipelines. Asia-Pacific is the fastest growing region with a high CAGR owing to the rise in prevalence of cancer and emerging economies like China and India.

Major companies dominating the Global Antibody Drug Conjugates Market are Seattle Genetics, Genentech, Takeda Pharmaceuticals, F. Hoffmann-La Roche, Bayer Healthcare, Agensys, Inc., Immunogen, Novartis, Oxford Biotherapeutics, and Synthon Biopharmaceuticals.

Browse through the full report at https://www.marketdataforecast.com/market-reports/antibody-drug-conjugates-market-6006/ and checkout our recent reports in the Pharmaceuticals  at https://www.marketdataforecast.com/subcategory/pharmaceuticals-1/  For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.